Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion N Goodson, P Wicks, J Morgan, L Hashem, S Callinan, J Reites NPJ Digital Medicine 5 (1), 58, 2022 | 76 | 2022 |
Methanobacterium paludis sp. nov. and a novel strain of Methanobacterium lacus isolated from northern peatlands H Cadillo-Quiroz, SL Bräuer, N Goodson, JB Yavitt, SH Zinder International journal of systematic and evolutionary microbiology 64 (Pt_5 …, 2014 | 59 | 2014 |
What role can decentralized trial designs play to improve rare disease studies? J Moore, N Goodson, P Wicks, J Reites Orphanet Journal of Rare Diseases 17 (1), 240, 2022 | 30 | 2022 |
Simultaneous deletion of Prdm1 and Vsx2 enhancers in the retina alters photoreceptor and bipolar cell fate specification, yet differs from deleting both genes NB Goodson, MA Kaufman, KU Park, JA Brzezinski IV Development 147 (13), dev190272, 2020 | 23 | 2020 |
Dark Carbon Fixation in the Columbia River’s Estuarine Turbidity Maxima: Molecular Characterization of Red-Type cbbL Genes and Measurement of DIC Uptake … SL Bräuer, K Kranzler, N Goodson, D Murphy, HM Simon, AM Baptista, ... Estuaries and coasts 36, 1073-1083, 2013 | 23 | 2013 |
Transcriptional profiling of murine retinas undergoing semi-synchronous cone photoreceptor differentiation ML Kaufman, KU Park, NB Goodson, S Chew, S Bersie, KL Jones, ... Developmental biology 453 (2), 155-167, 2019 | 22 | 2019 |
Prdm1 overexpression causes a photoreceptor fate-shift in nascent, but not mature, bipolar cells NB Goodson, KU Park, JS Silver, VA Chiodo, WW Hauswirth, ... Developmental biology 464 (2), 111-123, 2020 | 20 | 2020 |
Prdm13 is required for Ebf3+ amacrine cell formation in the retina NB Goodson, J Nahreini, G Randazzo, A Uruena, JE Johnson, ... Developmental biology 434 (1), 149-163, 2018 | 20 | 2018 |
Initiation of Otx2 expression in the developing mouse retina requires a unique enhancer and either Ascl1 or Neurog2 activity ML Kaufman, NB Goodson, KU Park, M Schwanke, E Office, ... Development 148 (12), dev199399, 2021 | 18 | 2021 |
Resilient design: decentralized trials recovered faster from the impact of COVID-19 than traditional site-based designs J Price, N Goodson, EJ Warren, P Wicks, J Reites Expert Review of Medical Devices 18 (sup1), 1-4, 2021 | 17 | 2021 |
Balancing extrasynaptic excitation and synaptic inhibition within olfactory bulb glomeruli DH Gire, JD Zak, JN Bourne, NB Goodson, NE Schoppa Eneuro 6 (4), 2019 | 12 | 2019 |
5HTR3A‐driven GFP labels immature olfactory sensory neurons TE Finger, DL Bartel, N Shultz, NB Goodson, CA Greer Journal of Comparative Neurology 525 (7), 1743-1755, 2017 | 10 | 2017 |
Office E, Schneider SR, Abraham J, Hensley A, Jones KL, Brzezinski JA (2021) Initiation of Otx2 expression in the developing mouse retina requires a unique enhancer and either … ML Kaufman, NB Goodson, KU Park, M Schwanke Development 148, 0 | 7 | |
Online randomised trials with children: A scoping review S Lepage, A Conway, N Goodson, P Wicks, L Flight, D Devane Plos one 18 (5), e0280965, 2023 | 3 | 2023 |
Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials N Goodson, P Wicks, C Farina Trials 23 (1), 966, 2022 | 3 | 2022 |
Online randomised trials with children: A scoping review protocol S Lepage, A Conway, N Goodson, P Wicks, D Devane HRB Open Research 5, 2022 | 2 | 2022 |
HRB Open Research S Lepage, A Conway, N Goodson, P Wicks, D Devane | | 2022 |
Keeping an eye on Otx2 targets J Brzezinski, N Goodson DEVELOPMENT 147 (13), 2020 | | 2020 |
Utilizing CRISPR to perturb photoreceptor/bipolar enhancer mediated cell fate decisions in the mouse retina N Goodson, JA Brzezinski Investigative Ophthalmology & Visual Science 60 (9), 6043-6043, 2019 | | 2019 |
Thresholding of sensory inputs by extrasynaptic glutamate receptors in olfactory bulb glomeruli DH Gire, JD Zak, JN Bourne, NB Goodson, BE Lynch, CG Dulla, ... bioRxiv, 341958, 2018 | | 2018 |